{"lastUpdatedAt": 1598414578943, "totalPosts": {"label": "Total Posts", "value": 24}, "totalComments": {"label": "Total Comments", "value": 27}, "postRate": {"title": "Post Rate", "data": [{"label": "2020-08-25T20:00:00.000+05:30", "value": 6}, {"label": "2020-08-25T21:00:00.000+05:30", "value": 3}, {"label": "2020-08-25T22:00:00.000+05:30", "value": 3}, {"label": "2020-08-25T23:00:00.000+05:30", "value": 2}, {"label": "2020-08-26T00:00:00.000+05:30", "value": 3}, {"label": "2020-08-26T01:00:00.000+05:30", "value": 3}, {"label": "2020-08-26T02:00:00.000+05:30", "value": 4}]}, "commentRate": {"title": "Comment Rate", "data": [{"label": "2020-08-26T07:00:00.000+05:30", "value": 18}, {"label": "2020-08-26T08:00:00.000+05:30", "value": 9}]}, "commentSentiments": {"title": "Comment Sentiments", "data": [{"name": "neutral", "value": 12}, {"name": "positive", "value": 11}, {"name": "negative", "value": 4}]}, "postSentiments": {"title": "Post Sentiments", "data": [{"name": "neutral", "value": 15}, {"name": "positive", "value": 5}, {"name": "negative", "value": 4}]}, "topStocks": {"title": "Top stocks", "data": [{"label": "GEVO", "value": 7}, {"label": "EVFM", "value": 4}, {"label": "SOLO", "value": 4}, {"label": "AVGR", "value": 3}, {"label": "HMHC", "value": 3}, {"label": "VIVE", "value": 3}, {"label": "HJLI", "value": 2}, {"label": "IDEX", "value": 2}, {"label": "MARA", "value": 2}, {"label": "PPSI", "value": 2}]}, "stockRatings": {"title": "Stock Ratings", "data": {"GEVO": {"score": {"P/B": 3, "ROA": 2, "DCF": 3, "P/E": 3, "ROE": 2, "D/E": 3}, "recommendation": {"P/B": "Neutral", "ROA": "Neutral", "DCF": "Neutral", "P/E": "Neutral", "ROE": "Sell", "D/E": "Sell"}}, "EVFM": {"score": {"P/B": 3, "ROA": 5, "DCF": 5, "P/E": 3, "ROE": 5, "D/E": 5}, "recommendation": {"P/B": "Neutral", "ROA": "Strong Buy", "DCF": "Strong Buy", "P/E": "Neutral", "ROE": "Strong Buy", "D/E": "Strong Buy"}}, "SOLO": {}, "AVGR": {"score": {"P/B": 3, "ROA": 2, "DCF": 3, "P/E": 3, "ROE": 2, "D/E": 3}, "recommendation": {"P/B": "Neutral", "ROA": "Neutral", "DCF": "Neutral", "P/E": "Neutral", "ROE": "Sell", "D/E": "Sell"}}, "HMHC": {"score": {"P/B": 3, "ROA": 2, "DCF": 4, "P/E": 3, "ROE": 2, "D/E": 4}, "recommendation": {"P/B": "Neutral", "ROA": "Buy", "DCF": "Buy", "P/E": "Neutral", "ROE": "Sell", "D/E": "Sell"}}, "VIVE": {"score": {"P/B": 5, "ROA": 2, "DCF": 3, "P/E": 3, "ROE": 2, "D/E": 3}, "recommendation": {"P/B": "Strong Buy", "ROA": "Neutral", "DCF": "Neutral", "P/E": "Neutral", "ROE": "Sell", "D/E": "Sell"}}, "HJLI": {}, "IDEX": {}, "MARA": {"score": {"P/B": 5, "ROA": 2, "DCF": 5, "P/E": 3, "ROE": 2, "D/E": 5}, "recommendation": {"P/B": "Strong Buy", "ROA": "Strong Buy", "DCF": "Strong Buy", "P/E": "Neutral", "ROE": "Sell", "D/E": "Sell"}}, "PPSI": {"score": {"P/B": 5, "ROA": 5, "DCF": 5, "P/E": 3, "ROE": 2, "D/E": 5}, "recommendation": {"P/B": "Strong Buy", "ROA": "Strong Buy", "DCF": "Strong Buy", "P/E": "Neutral", "ROE": "Sell", "D/E": "Strong Buy"}}}}, "enterprise": {"title": "Enterprise History", "data": {"GEVO": {"symbol": "GEVO", "stockPrice": 1.97, "numberOfShares": 12177910, "marketCapitalization": 23990482.7, "minusCashAndCashEquivalents": 16302000, "addTotalDebt": 233000, "enterpriseValue": 7921482.699999999}, "EVFM": {"symbol": "EVFM", "stockPrice": 5.16, "numberOfShares": 40228520, "marketCapitalization": 207579163.20000002, "minusCashAndCashEquivalents": 15571000, "addTotalDebt": 0, "enterpriseValue": 192008163.20000002}, "SOLO": {"symbol": "SOLO", "stockPrice": 2.06, "numberOfShares": 35998150, "marketCapitalization": 74156189, "minusCashAndCashEquivalents": 11095850, "addTotalDebt": 860870, "enterpriseValue": 63921209}, "AVGR": {"symbol": "AVGR", "stockPrice": 0.61, "numberOfShares": 7239000, "marketCapitalization": 4415790, "minusCashAndCashEquivalents": 10943000, "addTotalDebt": 0, "enterpriseValue": -6527210}, "HMHC": {"symbol": "HMHC", "stockPrice": 5.82, "numberOfShares": 124152980, "marketCapitalization": 722570343.6, "minusCashAndCashEquivalents": 296353000, "addTotalDebt": 638187000, "enterpriseValue": 1064404343.6}, "VIVE": {"symbol": "VIVE", "stockPrice": 1.03, "numberOfShares": 1247770, "marketCapitalization": 1285203.1, "minusCashAndCashEquivalents": 13308000, "addTotalDebt": 3983000, "enterpriseValue": -8039796.9}, "HJLI": {"symbol": "HJLI", "stockPrice": 0.61, "numberOfShares": 15760440, "marketCapitalization": 9613868.4, "minusCashAndCashEquivalents": 1307230, "addTotalDebt": 0, "enterpriseValue": 8306638.4}, "IDEX": {"symbol": "IDEX", "stockPrice": 0.62, "numberOfShares": 119766860, "marketCapitalization": 74255453.2, "minusCashAndCashEquivalents": 2632890, "addTotalDebt": 9639510, "enterpriseValue": 81262073.2}, "MARA": {"symbol": "MARA", "stockPrice": 1.07, "numberOfShares": 6664240, "marketCapitalization": 7130736.800000001, "minusCashAndCashEquivalents": 694100, "addTotalDebt": 999110, "enterpriseValue": 7435746.800000001}, "PPSI": {"symbol": "PPSI", "stockPrice": 2.17, "numberOfShares": 8726000, "marketCapitalization": 18935420, "minusCashAndCashEquivalents": 8213000, "addTotalDebt": 920000, "enterpriseValue": 11642420}}}, "profile": {"title": "Company Profile", "data": {"GEVO": {"symbol": "GEVO", "price": 1.48, "beta": 2.13811, "volAvg": 25535215, "mktCap": 79677728, "lastDiv": 0.0, "range": "0.46-3.6", "changes": 0.09, "companyName": "Gevo Inc", "exchange": "NASDAQ Capital Market", "exchangeShortName": "NASDAQ", "industry": "Specialty Chemicals", "website": "http://www.gevo.com/", "description": "Gevo, Inc. is a renewable chemicals and next generation biofuels company, which focuses on the development and commercialization of renewable alternatives to petroleum-based products. The company is headquartered in Englewood, Colorado and currently employs 52 full-time employees. The firm has developed a technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstock. The company has two operating segments: the Gevo, Inc. segment and the Gevo Development/Agri-Energy segment. Its Gevo, Inc. segment is responsible for research and development activities related to the future production of isobutanol, including the development of its biocatalysts, the production and sale of biojet fuel, its Retrofit process and the next generation of chemicals and biofuels that will be based on its isobutanol technology. Its Gevo Development/Agri-Energy segment is responsible for the operation of its Agri-Energy Facility and the production of ethanol, isobutanol and related products.", "ceo": "Dr. Patrick Gruber", "sector": "Basic Materials", "country": "US", "fullTimeEmployees": "57", "phone": "13038588358", "address": "Building C, 345 Inverness Dr S Ste 310", "city": "Building C, 345 Inverness Dr S Ste 310", "state": "COLORADO", "zip": "80112", "dcfDiff": -11084.8, "dcf": -11082.7, "image": "https://financialmodelingprep.com/image-stock/GEVO.jpg"}, "EVFM": {"symbol": "EVFM", "price": 3.2, "beta": 0.24155, "volAvg": 4244128, "mktCap": 260096976, "lastDiv": 0.0, "range": "2.73-7.5", "changes": 0.14, "companyName": "Evofem Biosciences Inc", "exchange": "NASDAQ Capital Market", "exchangeShortName": "NASDAQ", "industry": "Biotechnology", "website": "https://www.evofem.com/", "description": "Evofem Biosciences, Inc. develops therapeutic solutions to meet sexual and reproductive health needs of women. The company is headquartered in San Diego, California and currently employs 30 full-time employees. The firm develops products to address unmet needs in women's sexual and reproductive health. The Company\u2019s product Amphora, is a Multipurpose Vaginal pH Regulator (MVP-R) designed to regulate vaginal pH to within the normal range of 3.5 to 4.5 even in the presence of semen. This maintains an acidic environment which is inhospitable to sperm as well as certain viral and bacterial pathogens associated with sexually transmitted infections. Amphora is used to prevent urogenital chlamydia and gonorrhea in women. The firm is in the second Phase III clinical trial of Amphora for prevention of pregnancy (AMP002). The firm is currently designing a Phase IIb trial for its second product candidate, a MVP-R to reduce the recurrence of bacterial vaginosis.", "ceo": "Ms. Saundra Pelletier", "sector": "Healthcare", "country": "US", "fullTimeEmployees": "53", "phone": "18585501900", "address": "12400 High Bluff Dr Ste 600", "city": "12400 High Bluff Dr Ste 600", "state": "CALIFORNIA", "zip": "92130", "dcfDiff": -4.01, "dcf": 0.0, "image": "https://financialmodelingprep.com/image-stock/EVFM.jpg"}, "SOLO": {"symbol": "SOLO", "price": 3.01, "beta": 1.384469, "volAvg": 14780607, "mktCap": 193005712, "lastDiv": 0.0, "range": "0.89-6.0", "changes": 0.18, "companyName": "Electrameccanica Vehicles Corp", "exchange": "NasdaqCM", "exchangeShortName": "NASDAQ", "industry": "Auto Manufacturers", "website": "https://electrameccanica.com/", "description": "Electrameccanica Vehicles Corp. engages in development and manufacture of electric vehicles. The company is headquartered in Vancouver, British Columbia. The firm is dedicated to the design and manufacture of electric vehicles. The firm operates in two reportable business segments in Canada, Electric Vehicles and Custom build vehicles. Electric Vehicles segment includes development and manufacture of electric vehicles for mass markets. Custom build vehicles segment includes development and manufacture of high-end custom built vehicles. The firm has designed and built all-electric SOLO, a single-seater electric vehicle. The company has also designed the Tofino, electric two seater roadster set.", "ceo": "Mr. Michael Paul Rivera", "sector": "Consumer Cyclical", "country": "CA", "fullTimeEmployees": "63", "phone": "16044287656", "address": "102 1st Ave E", "city": "102 1st Ave E", "state": "BRITISH COLUMBIA", "zip": "V5T 1A4", "dcfDiff": null, "dcf": null, "image": "https://financialmodelingprep.com/image-stock/SOLO.jpg"}, "AVGR": {"symbol": "AVGR", "price": 0.5259, "beta": 1.53451, "volAvg": 9977693, "mktCap": 38126120, "lastDiv": 0.0, "range": "0.241-1.63", "changes": 0.0479, "companyName": "Avinger Inc", "exchange": "NASDAQ Capital Market", "exchangeShortName": "NASDAQ", "industry": "Medical Devices", "website": "http://avinger.com/", "description": "Avinger, Inc. manufactures catheter devices used to treat vascular diseases. The company is headquartered in Redwood City, California and currently employs 70 full-time employees. The firm designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The firm focuses on introducing products based on its lumivascular platform, which is an intravascular image-guided system. The firm manufactures and sells a suite of products in the United States and certain European markets. The firm's products include Lightbox imaging console, as well as its Wildcat, Kittycat and the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO). The lumivascular platform offers real-time visualization of the inside of the artery during PAD treatment. The lumivascular platform consists of a capital component Lightbox and a range of disposable catheter products, including Ocelot, Ocelot PIXL, Ocelot MVRX and Pantheris.", "ceo": "Mr. Jeffrey Soinski", "sector": "Healthcare", "country": "US", "fullTimeEmployees": "81", "phone": "16503632400", "address": "400 Chesapeake Dr", "city": "400 Chesapeake Dr", "state": "CALIFORNIA", "zip": "94063", "dcfDiff": -13.73, "dcf": -12.72, "image": "https://financialmodelingprep.com/image-stock/AVGR.jpg"}, "HMHC": {"symbol": "HMHC", "price": 2.19, "beta": 1.51195, "volAvg": 4991521, "mktCap": 275567712, "lastDiv": 0.0, "range": "1.03-6.85", "changes": 0.0, "companyName": "Houghton Mifflin Harcourt Co", "exchange": "Nasdaq Global Select", "exchangeShortName": "NASDAQ", "industry": "Education & Training Services", "website": "http://ir.hmhco.com./", "description": "Houghton Mifflin Harcourt Co. engages in the provision of pre-K-12 education solutions, delivering content, technology, services, and media. The company is headquartered in Boston, Massachusetts and currently employs 3,600 full-time employees. The firm operates through two segments: Education and Trade Publishing. As of December 31, 2016, the Company delivered content, services and technology to both educational institutions and consumers, reaching over 50 million students in approximately 150 countries across the world. The company sells its products and services across multiple media and distribution channels. Its Education segment provides educational content, services and technology solutions to meet the diverse needs of classrooms. Its Trade Publishing segment develops, markets and sells consumer books in print and digital formats, and licenses book rights to other publishers and electronic businesses in the United States and abroad.", "ceo": "Mr. John Lynch", "sector": "Consumer Defensive", "country": "US", "fullTimeEmployees": "3400", "phone": "16173515000", "address": "125 High St", "city": "125 High St", "state": "MASSACHUSETTS", "zip": "02110", "dcfDiff": null, "dcf": 0.0, "image": "https://financialmodelingprep.com/image-stock/HMHC.jpg"}, "VIVE": {"symbol": "VIVE", "price": 0.71, "beta": 0.42733, "volAvg": 1089118, "mktCap": 11171211, "lastDiv": 0.0, "range": "0.525-11.9", "changes": 0.18, "companyName": "Viveve Medical Inc", "exchange": "NASDAQ Capital Market", "exchangeShortName": "NASDAQ", "industry": "Medical Devices", "website": "https://us.viveve.com/", "description": "Viveve Medical, Inc. is a medical technology company focused on women's intimate health. The company is headquartered in Englewood, Colorado and currently employs 67 full-time employees. The Company's, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System (a radio frequency (RF), generator housed in a table-top console), a reusable handpiece and a single-use treatment tip, as well as several other consumable accessories. Physicians attach the single-use treatment tip to the handpiece, which is connected to the console. The generator authenticates the treatment tip and programs the system for the desired treatment without further physician intervention. The treatment is performed in a physician's office, in less than 30 minutes, and does not require the use of anesthesia. Geneveve is indicated for use in general surgical procedures for electrocoagulation and hemostasis in the United States.", "ceo": "Mr. Scott Durbin", "sector": "Healthcare", "country": "US", "fullTimeEmployees": "55", "phone": "14085301900", "address": "345 Inverness Dr S Bldg B Ste 250", "city": "345 Inverness Dr S Bldg B Ste 250", "state": "COLORADO", "zip": "80112", "dcfDiff": -1.01, "dcf": 0.0, "image": "https://financialmodelingprep.com/image-stock/VIVE.jpg"}, "HJLI": {"symbol": "HJLI", "price": 0.44, "beta": 0.0, "volAvg": 10483157, "mktCap": 16862692, "lastDiv": 0.0, "range": "0.211-1.08", "changes": 0.045, "companyName": "Hancock Jaffe Laboratories Inc", "exchange": "NasdaqCM", "exchangeShortName": "NASDAQ", "industry": "Medical Devices", "website": "http://www.hancockjaffe.com/", "description": "Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. The company is headquartered in Irvine, California and currently employs 9 full-time employees. The firm is developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). The firm is in the process of developing bioprosthetic implantable devices for cardiovascular disease. The Company\u2019s Bioprosthetic Heart Valve (BHV), is a bioprosthetic, pig heart valve designed to function like a native heart valve, and designed to provide a patient greater functional performance than available devices. The Company\u2019s product Venous Valve is a bioprosthetic, pig venous valve for patients with lower limb chronic venous insufficiency (CVI), which occurs because of damage to the valves of the veins in the legs after patients develop blood clots in the deep venous system.", "ceo": "Mr. Robert A. Berman", "sector": "Healthcare", "country": "US", "fullTimeEmployees": "12", "phone": "19492612900", "address": "70 Doppler", "city": "70 Doppler", "state": "CALIFORNIA", "zip": "92618", "dcfDiff": null, "dcf": null, "image": "https://financialmodelingprep.com/image-stock/HJLI.jpg"}, "IDEX": {"symbol": "IDEX", "price": 1.26, "beta": -2.09665, "volAvg": 36638075, "mktCap": 299001792, "lastDiv": 0.0, "range": "0.28-3.98", "changes": 0.06, "companyName": "Ideanomics Inc", "exchange": "NasdaqCM", "exchangeShortName": "NASDAQ", "industry": "Software Application", "website": "https://ideanomics.com/", "description": "Ideanomics, Inc. provides cloud-based software and services. The company is headquartered in New York City, New York and currently employs 50 full-time employees. The firm focuses on BASE technology and infrastructure including Blockchain, artificial intelligence, supply chain and exchanges to the virtual platform as a service (v pass). Its business units include smart intellectual property cloud, smart sales cloud products and transactional cloud. The firm is engaged in creating closed trade ecosystem for buyers and sellers. The firm creates a vertical, transactional platform for global enterprise.", "ceo": "Mr. Alfred Poor", "sector": "Technology", "country": "US", "fullTimeEmployees": "60", "phone": "12122061216", "address": "55 Broadway Fl 19", "city": "55 Broadway Fl 19", "state": "NEW YORK", "zip": "10006", "dcfDiff": null, "dcf": null, "image": "https://financialmodelingprep.com/image-stock/IDEX.jpg"}, "MARA": {"symbol": "MARA", "price": 2.44, "beta": 2.84813, "volAvg": 16816795, "mktCap": 78428920, "lastDiv": 0.0, "range": "0.35-5.25", "changes": 0.13, "companyName": "Marathon Patent Group Inc", "exchange": "NASDAQ Capital Market", "exchangeShortName": "NASDAQ", "industry": "Capital Markets", "website": "https://www.marathonpg.com/", "description": "Marathon Patent Group, Inc. is a digital asset technology company, which mines cryptocurrencies, with a focus on the blockchain ecosystem and the generation of digital assets. The company is headquartered in Las Vegas, Nevada and currently employs 3 full-time employees. The firm focuses on the blockchain ecosystem and the generation of digital assets. The firm is operating one mining facility in Quebec, with plans to open additional facilities in the future. The firm offers managed mining solutions on its robust proprietary infrastructure and smart mining software. The firm intends to power and secure blockchains by verifying blockchain transactions using custom hardware and software. The company is using its hardware to mine bitcoin (BTC) and expect to mine BTC and ether (ETH), and potentially other cryptocurrencies.", "ceo": "Mr. Merrick Okamoto", "sector": "Financial Services", "country": "US", "fullTimeEmployees": "3", "phone": "18008041690", "address": "1180 N Town Center Dr Ste 100", "city": "1180 N Town Center Dr Ste 100", "state": "NEVADA", "zip": "89144", "dcfDiff": -162.3, "dcf": -159.17, "image": "https://financialmodelingprep.com/image-stock/MARA.jpg"}, "PPSI": {"symbol": "PPSI", "price": 2.35, "beta": 0.4824, "volAvg": 369218, "mktCap": 20506194, "lastDiv": 0.0, "range": "0.9-6.19", "changes": 0.95, "companyName": "Pioneer Power Solutions Inc", "exchange": "NASDAQ Capital Market", "exchangeShortName": "NASDAQ", "industry": "Electrical Equipment & Parts", "website": "https://www.pioneerpowersolutions.com/", "description": "Pioneer Power Solutions, Inc. engages in the manufacture, sale and distribution of on-site power generation equipment for applications in the industrial, commercial and backup power markets. The company is headquartered in Fort Lee, New Jersey and currently employs 365 full-time employees. The firm's principal products and services include custom low and medium voltage switchgear and engine-generator sets and controls. The firm operates through two segments: Transmission & Distribution Solutions (T&D Solutions) and Critical Power Solutions (Critical Power). Its Critical Power business provides customers with power generation equipment, paralleling switchgear, related electrical distribution infrastructure, and a data collection and monitoring platform. These solutions are marketed by its operations in Minneapolis, doing business under the Pioneer Critical Power Inc. and Titan Energy Systems Inc. brand names.", "ceo": "Mr. Nathan Mazurek", "sector": "Industrials", "country": "US", "fullTimeEmployees": "95", "phone": "12128670700", "address": "400 Kelby St Ste 12", "city": "400 Kelby St Ste 12", "state": "NEW JERSEY", "zip": "07024", "dcfDiff": -5.23, "dcf": 0.0, "image": "https://financialmodelingprep.com/image-stock/PPSI.jpg"}}}}